ProShare Advisors
ZYME icon

ProShare Advisors’s Zymeworks ZYME Stock Holding History

ProShare Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Sell
8,557
-2,017
-19% -$51.2K ﹤0.01% 1579
2026
Q1 		$265K Sell
10,574
-1,813
-15% -$42.9K ﹤0.01% 1400
2025
Q4 		$326K Buy
12,387
+1,186
+11% +$25.9K ﹤0.01% 1402
2025
Q3 		$191K Sell
11,201
-1,464
-12% -$21K ﹤0.01% 1703
2025
Q2 		$159K Sell
12,665
-2,247
-15% -$26.8K ﹤0.01% 1779
2025
Q1 		$178K Sell
14,912
-3,711
-20% -$50.6K ﹤0.01% 1724
2024
Q4 		$273K Sell
18,623
-10,889
-37% -$152K ﹤0.01% 1699
2024
Q3 		$370K Buy
29,512
+17,658
+149% +$192K ﹤0.01% 1325
2024
Q2 		$101K Sell
11,854
-3,098
-21% -$27.6K ﹤0.01% 1665
2024
Q1 		$157K Buy
14,952
+1,499
+11% +$16.6K ﹤0.01% 1731
2023
Q4 		$140K Buy
+13,453
New +$107K ﹤0.01% 1727

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

ProShare Advisors's ZYME Position: Q2 2026 in Review

ProShare Advisors reduced its Zymeworks (ZYME) stake by 19% in Q2 2026, selling an estimated $51.2K and leaving 8,557 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #1579.

ProShare Advisors first reported a position in ZYME in Q4 2023 and has held it in 11 quarters since. The position peaked at $370K in Q3 2024. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • ProShare Advisors held 8,557 shares of Zymeworks worth $224K as of Q2 2026.
  • ProShare Advisors sold 2,017 Zymeworks shares in Q2 2026, an estimated $51.2K.
  • Zymeworks made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1579 holding.
  • ProShare Advisors first reported a position in Zymeworks in Q4 2023 and has held it in 11 quarters since.
  • ProShare Advisors's Zymeworks position peaked at $370K in Q3 2024.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.